“Cure for Type 1 Diabetes Imminent After Harvard Stem Cell Breakthrough.” I’ve seen these headlines on Facebook (FB) before, often rolling my eyes and moving along. When I saw that FB headline on Sunday, I reacted differently.Keep reading
- Views October 14, 2015
- News October 13, 2015
Kuhl will champion the practice’s pharmaceutical efforts focusing on biotechnology, pharmaceutical, specialty pharma and orphan drug clients.Keep reading
- Views October 13, 2015
Facebook and Twitter are notorious testers -- they're constantly rolling out soft tests of new site functionality while leaving most users in the dark.
Last week, both social channels launched new features that we hope are here to stay: Facebook Reactions and Twitter Moments.Keep reading
- Views October 6, 2015
We know what happened on the ground at Dreamforce 2015, but we decided to dive a bit deeper to get a sense of how it played out across social channels.Keep reading
- Views October 2, 2015
According to the Fox News poll on September 18, Donald Trump is in the lead with a 25% approval rating, ahead of Ben Carson (12%), Ted Cruz (10%), Jeb Bush (9%), and Mike Huckabee (6%).
- News September 22, 2015
We announced today the appointment of Ovidio Torres as partner, and Kristen Berry, associate vice president, as part of the our growing national Health Practice. Both will be based in the agency’s Chicago office.
- Views September 21, 2015
From fitness trackers and smart watches, to clothing with built-in sensors, wearables are entering the market at an increasingly rapid rate. When will one device be enough to accurately track all of our data? What is the point of tracking all of this data and how can it make an impact on our lives beyond letting us know how many steps we take a day?Keep reading
- News September 10, 2015
I’m very pleased to announce that we have finalized an agreement to acquire Horn Group, a well-known NY and San Francisco based agency specializing in tech PR. We’re excited to bring Founder Sabrina Horn -- one of the tech industry’s most highly regarded luminaries – into the fold.
- Views September 8, 2015
In recent years, the U.S. health care system has undergone massive change - from patient care to medical e-records to drug formularies and, most recently, access to insurance coverage. It is often a major challenge navigating this evolving system, and individual experience depends heavily on one’s role and function within the system - provider, payer, policymaker, pharma or patient.Keep reading
- Views August 27, 2015
In the past months, the Food and Drug Administration (FDA) has approved for market a steady stream of acknowledged breakthrough medicines for hepatitis C, LDL cholesterol and cancer immuno-therapy. The Agency has affirmed that it is approving drugs at a consistent pace. But what makes a new medicine “innovative?”